Stockscreener 앱 받기
4.68
3.51%
-0.17
시간 외 거래:
4.67
-0.010
-0.21%
전일 마감가:
$4.85
열려 있는:
$4.83
하루 거래량:
7.44M
Relative Volume:
1.28
시가총액:
$830.58M
수익:
$2.54B
순이익/손실:
$-207.36M
주가수익비율:
-3.9328
EPS:
-1.19
순현금흐름:
$151.25M
1주 성능:
-4.68%
1개월 성능:
-37.27%
6개월 성능:
-30.97%
1년 성능:
-64.11%
1일 변동 폭
$4.53
$4.8383
1주일 범위
$4.53
$5.075
52주 변동 폭
$4.53
$15.21
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
4.68 | 860.75M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
177.04 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
53.61 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.06 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
25.96 | 5.03B | 550.17M | 201.35M | 232.07M | 1.00 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-07-25 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Buy |
| 2024-09-17 | 재확인 | Jefferies | Hold |
| 2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
| 2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-06 | 재확인 | BofA Securities | Neutral |
| 2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-03 | 업그레이드 | Argus | Hold → Buy |
| 2022-02-23 | 재확인 | BofA Securities | Neutral |
| 2022-02-23 | 재확인 | Craig Hallum | Hold |
| 2022-02-23 | 재확인 | Evercore ISI | In-line |
| 2022-02-23 | 재확인 | Goldman | Buy |
| 2022-02-23 | 재확인 | JP Morgan | Overweight |
| 2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 재확인 | Needham | Buy |
| 2022-02-23 | 재확인 | Oppenheimer | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-08 | 재확인 | Piper Sandler | Overweight |
| 2021-12-02 | 재개 | Jefferies | Hold |
| 2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-28 | 재확인 | Barclays | Equal Weight |
| 2021-10-28 | 재확인 | BofA Securities | Neutral |
| 2021-10-28 | 재확인 | Canaccord Genuity | Buy |
| 2021-10-28 | 재확인 | Citigroup | Buy |
| 2021-10-28 | 재확인 | Craig Hallum | Hold |
| 2021-10-28 | 재확인 | Needham | Buy |
| 2021-10-28 | 재확인 | Oppenheimer | Outperform |
| 2021-10-28 | 재확인 | Piper Sandler | Overweight |
| 2021-10-28 | 재확인 | UBS | Neutral |
| 2021-10-19 | 개시 | Wells Fargo | Overweight |
| 2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
| 2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-22 | 개시 | Evercore ISI | In-line |
| 2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 개시 | Goldman | Neutral |
| 2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-07-13 | 개시 | Argus | Buy |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 개시 | UBS | Neutral |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
Here's Why I Still Wouldn't Touch Teladoc With a 10‑Foot Pole - Nasdaq
Teladoc Health expands virtual care access through HealthKey partnership - Traders Union
Teladoc Health (NYSE:TDOC) Sets New 12-Month LowHere's What Happened - MarketBeat
HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? - Finviz
Telemedicine Market to Reach US$ 488.89 Billion by 2033 at 16.8% - openPR.com
Dow Update: Is Teladoc Health Inc. stock positioned for long term growthTrade Ideas & Short-Term High Return Strategies - mfd.ru
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Digital Health Market to Reach US$ 1,907.21 Billion by 2033, - openPR.com
Online Doctor Consultation Market Set for Explosive Growth - openPR.com
Stock Market Today, Feb. 9: Hims & Hers Health Drops 16% on Novo Nordisk Lawsuit - The Motley Fool
Teladoc (TDOC) Sees Increased Bullish Activity in Options Market - GuruFocus
Allianz Asset Management GmbH Grows Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
United States Telehealth Solutions Market to Grow at 32.1% CAGR - openPR.com
Teladoc (TDOC) Sees Surge in Bullish Option Activity - GuruFocus
Best Telemedicine and Telehealth Stocks for 2026 - The Motley Fool
Teladoc Health, Inc. $TDOC Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of "Hold" by Analysts - MarketBeat
Can Teladoc Health Inc reach all time highs this year - baoquankhu1.vn
Teladoc Health drives confidence in hypertension care - Traders Union
Teladoc Health to Announce Fourth Quarter 2025 Financial Results - The Manila Times
Jim Cramer on Teladoc: "I Don't See Any Reason to Own It" - Finviz
Jim Cramer on Teladoc: “I Don’t See Any Reason to Own It” - Insider Monkey
Lacklustre Performance Is Driving Teladoc Health, Inc.'s (NYSE:TDOC) 28% Price Drop - 富途牛牛
Teladoc Health, Inc.'s (NYSE:TDOC) 28% Dip In Price Shows Sentiment Is Matching Revenues - simplywall.st
Teladoc Health, Inc. (TDOC) Investor Outlook: Is The 66% Upside Within Reach? - DirectorsTalk Interviews
The Truth About Teladoc Health Inc: Is TDOC’s Telehealth Empire Still Worth Your Money? - AD HOC NEWS
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Teladoc Health (NYSE:TDOC) Hits New 12-Month LowHere's Why - MarketBeat
Teladoc Health (TDOC) Is Down 13.9% After Medicare Tightens Telehealth CoverageWhat's Changed - Sahm
(TDOC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
A Look At Teladoc Health’s Valuation As Medicare Telehealth Policy And Options Activity Drive Uncertainty - Sahm
What are Teladoc Health Inc.’s earnings expectationsJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Chuck Divita on why 2026 is Teladoc’s ‘execution year’ - Healthcare Dive
Teladoc hits all-time low as a risky pattern points to a deeper dive - TradingView
Published on: 2026-01-29 14:18:31 - baoquankhu1.vn
Teleoncology Market to Reach US$ 15.03 Billion by 2032 at 15.7% - openPR.com
A Look At Teladoc Health (TDOC) Valuation As Medicare And BetterHelp Concerns Drive Volatility - Yahoo Finance
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Globe and Mail
Medicare Telehealth Uncertainty And BetterHelp Weakness Test Teladoc Valuation - Sahm
Is Teladoc Health (TDOC) A Potential Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Teladoc (TDOC) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Why Teladoc (TDOC) Shares Are Plunging Today - Finviz
Teladoc Health (NYSE:TDOC) Hits New 1-Year LowShould You Sell? - MarketBeat
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
Teladoc stock hits 52-week low at 6.03 USD - Investing.com
Teladoc price target lowered to $7 from $7.50 at BofA Securities - Investing.com Canada
Teladoc (TDOC) Sees Surge in Call Option Activity - GuruFocus
Teladoc offers free non-emergency care for Texans impacted by winter storm - CW33.com
Analyst Calls: What is the target price for Teladoc Health Inc stockQuarterly Market Summary & Growth Focused Entry Point Reports - baoquankhu1.vn
Teladoc’s Data-Driven 24/7 Care Upgrade Could Be A Game Changer For Teladoc Health (TDOC) - Sahm
Assessing Teladoc Health (TDOC) Valuation As Investor Caution Grows Despite Product Updates - Sahm
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
0.00%
자본화:
|
볼륨(24시간):